Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read MoreIt is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read MoreEquity strategist Michael Wilson highlighted several quality and defensive names that are rated overweight by Morgan Stanley analysts. Source link
Read MoreFor investors who want to find safe plays amid a volatile market, there's a whole set of large-cap names —
Read MoreThese dividend stocks are poised to move higher after the Federal Reserve starts cutting rates, says BMO. Source link
Read MoreWhile Nvidia tanked by nearly 12% last month, stocks identified by CNBC Pro rose by 9%. Source link
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read More"This election is likely to produce distinct, binary, opposing health policy outcomes depending on who wins," Raymond James analyst Chris
Read MoreResults are coming at a time when investors are on edge, uncertain where markets are heading after a pushback in
Read MoreInvestors searching for income could be well-rewarded by turning to dividend-growing stocks, according to Jefferies. Source link
Read More